Business Context and Reporting Period
Company: Henry Schein, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 30, 2018
Context: The filing discloses an anticipated settlement regarding the proposed class-action litigation In Re Dental Supplies Antitrust Litigation (No. 1:16-CV-00696-BMC-GRB) in the United States District Court for the Eastern District of New York.
Key Financial Metrics
This filing does not report full-period revenue, profit, cash flow, margins, debt, or liquidity metrics. It specifically addresses a single anticipated financial impact:
- Anticipated Pre-Tax Charge: $38.5 million
- Anticipated Per-Share Impact: $0.19 per share
- Timing of Recognition: Expected to be recorded in the third-quarter 2018 results.
Material Changes and Unusual Items
The primary material change disclosed is the expectation of a significant one-time charge related to the antitrust litigation settlement. This charge is unusual in nature as it stems from a legal settlement rather than ongoing operational activities. The filing notes that the settlement is subject to reaching a definitive agreement among the parties and subsequent court approval.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release and Q&A regarding the settlement. Management emphasizes that the settlement is prospective and not yet finalized.
Risks and Contingencies:
- Settlement Uncertainty: No assurances can be made that the prospective settlement will be finalized, that a definitive agreement will be executed, or that the court will approve the settlement.
- Forward-Looking Statements: The filing includes standard safe harbor language regarding risks such as market competition, supply chain dependence, currency fluctuations, regulatory changes, and the potential spin-off/merger of the animal health business with Direct Vet Marketing, Inc. (Vets First Choice).
- Other Litigation: Investors are directed to the most recent Form 10-Q for details on litigation matters other than the one addressed in this filing.
Investor Verification Checklist
- Verify the finalization of the definitive settlement agreement for In Re Dental Supplies Antitrust Litigation.
- Confirm court approval of the settlement terms.
- Review the third-quarter 2018 earnings release to confirm the actual recording of the $38.5 million pre-tax charge.
- Monitor updates regarding the spin-off and merger of the animal health business with Vets First Choice.
- Check the most recent Form 10-Q for status updates on other pending litigation not covered in this 8-K.